• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 385101
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/17/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.Date of event: unknown.The date received by manufacturer has been used as a default.
 
Event or Problem Description
It was reported bd q-syte extension set leaked at the luer connection.The following information was provided by the initial reporter: "leakage from q-syte and extension tube luer-port".
 
Additional Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.Date of event: unknown.The date received by manufacturer has been used as a default.
 
Event or Problem Description
It was reported bd q-syte extension set leaked at the luer connection.The following information was provided by the initial reporter: "leakage from q-syte and extension tube luer-port".
 
Additional Manufacturer Narrative
H6: investigation: our quality engineer inspected the 1 photo submitted for evaluation.The reported issue was not confirmed upon inspection of the photo.No damages or defects that could result in leakage were observed in the supplied photo.Bd cannot confirm the cause of the failure to our manufacturing process since no sample was returned for evaluation.A device history record review showed no non-conformances associated with this issue during the production of this batch.
 
Event or Problem Description
It was reported bd q-syte extension set leaked at the luer connection.The following information was provided by the initial reporter: "leakage from q-syte and extension tube luer-port".
 
Additional Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes, d10: returned to manufacturer on: 11-mar-2022.H6: investigation summary our quality engineer inspected the 1 sample submitted for evaluation.The reported issue was not confirmed upon inspection and testing of the sample.During inspection no damages or abnormalities were observed on the sample.The sample was functionally tested for the reported defect of leakage and during testing the sample showed no signs of leakage.Bd cannot determine a manufacturing root cause of the failure since the defect was not confirmed during testing.A device history record review showed no non-conformances associated with this issue during the production of this batch.H3 other text : see h10.
 
Event or Problem Description
It was reported bd q-syte extension set leaked at the luer connection.The following information was provided by the initial reporter: "leakage from q-syte and extension tube luer-port".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE EXTENSION SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key13423579
Report Number9610847-2022-00038
Device Sequence Number11750458
Product Code FPA
UDI-Device Identifier30382903851011
UDI-Public30382903851011
Combination Product (Y/N)N
Initial Reporter CountryTW
PMA/510(K) Number
K142527
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date03/31/2026
Device Model Number385101
Device Catalogue Number385101
Device Lot Number1082694
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/17/2022
Supplement Date Received by Manufacturer03/01/2022
04/04/2022
Initial Report FDA Received Date02/02/2022
Supplement Report FDA Received Date03/31/2022
04/22/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/28/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-